Direct Healthcare Professional Communication on the significant update to the posology and method of administration for new and existing patients treated with Vabysmo in Northern Ireland to align with the UK Summary of Product Characteristics (SmPC), as a result of the Windsor Framework Agreement.

This information is applicable to Healthcare Professionals based in Northern Ireland only.